Moxifloxacin associated vanishing bile duct syndrome

J Clin Gastroenterol. 2010 Jan;44(1):72-3. doi: 10.1097/MCG.0b013e3181a51af9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / adverse effects*
  • Aza Compounds / administration & dosage
  • Aza Compounds / adverse effects*
  • Azithromycin / adverse effects
  • Bile Duct Diseases / chemically induced*
  • Ceftriaxone / adverse effects
  • Fluoroquinolones
  • Humans
  • Male
  • Moxifloxacin
  • Quinolines / administration & dosage
  • Quinolines / adverse effects*
  • Syndrome

Substances

  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Ceftriaxone
  • Azithromycin
  • Moxifloxacin